Media/Policy Watch

Media/Policy Watch

This watch section is intended to alert readers to substantive news, analysis and opinion from the general media and selected think tanks and similar organizations on vaccines, immunization, global public health and related themes. Media Watch is not intended to be exhaustive, but indicative of themes and issues CVEP is actively tracking. This section will grow from an initial base of newspapers, magazines and blog sources, and is segregated from Journal Watch above which scans the peer-reviewed journal ecology.

We acknowledge the Western/Northern bias in this initial selection of titles and invite suggestions for expanded coverage. We are conservative in our outlook in adding news sources which largely report on primary content we are already covering above. Many electronic media sources have tiered, fee-based subscription models for access. We will provide full-text where content is published without restriction, but most publications require registration and some subscription level.
 
Forbes
http://www.forbes.com/
Accessed 5 May 2018
Merck Teams With Moderna To Take On One Of The Toughest Targets In Cancer
Matthew Herper, Forbes Staff
3 May 2018
Merck is making a $125 million investment in Moderna as part of a new funding round. “We’re encouraged by the potential for RNA-based vaccines,” says Eric Rubin, a Merck vice president.

Medicine As Currency For Peace: How Global Health Funding Could Change The World
3 May 2018
By Bill Frist